Back to Search
Start Over
The Neuropeptides of Ocular Immune Privilege, α-MSH and NPY, Suppress Phagosome Maturation in Macrophages.
- Source :
-
ImmunoHorizons [Immunohorizons] 2018 Nov; Vol. 2 (10), pp. 314-323. - Publication Year :
- 2018
-
Abstract
- The ocular microenvironment has evolutionarily adapted several mechanisms of immunosuppression to minimize the induction of inflammation. Neuropeptides produced by the retinal pigment epithelial cells regulate macrophage activity. Two neuropeptides, α-melanocyte-stimulating hormone (α -MSH) and neuropeptide Y (NPY), are constitutively expressed by the retinal pigment epithelial cells. Together these two neuropeptides induce anti-inflammatory cytokine production in endotoxin-stimulated macrophages and suppress phagocytosis of unopsonized bioparticles. These neuropeptides do not suppress the phagocytosis of opsonized bioparticles; however, they do suppress phagolysosome activation or formation. In this report, we studied the possibility that α-MSH with NPY suppress phagosome maturation within macrophages using opsonized OVA-coated magnetic beads to isolate and analyze the phagosomes. The magnetic bead-containing intercellular vesicles were isolated and assayed for Rab5, Rab7, LAMP1, Ia <superscript>d</superscript> , and OVA. The macrophages cotreated with α-MSH and NPY were suppressed in Rab7 recruitment to the phagosome with suppression in LAMP1 expression but not in Ia <superscript>d</superscript> expression. The results demonstrated that the α-MSH/NPY cotreatment suppressed phagosome maturation. In addition, the a-MSH/NPY-cotreated macrophages were suppressed in their ability to Ag stimulate CD4 <superscript>+</superscript> T cell proliferation. These results imply a potential mechanism of ocular immune privilege to divert Ag processing to prevent autoreactive effector T cells from binding their target cognate Ag within the ocular microenvironment.<br />Competing Interests: DISCLOSURES A.W.T. is a consultant for Palatin Technologies, Cranbury, NJ. The other authors have no financial conflicts of interest.
Details
- Language :
- English
- ISSN :
- 2573-7732
- Volume :
- 2
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- ImmunoHorizons
- Publication Type :
- Academic Journal
- Accession number :
- 30613828
- Full Text :
- https://doi.org/10.4049/immunohorizons.1800049